Congratulations all AXT shareholders, your company has announced 22 Release from ËSCROW Appendix 3B’s and drilled two holes almost through to China WELL DONE!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%